2016
DOI: 10.1002/epi4.4
|View full text |Cite
|
Sign up to set email alerts
|

Not all that glitters is gold: A guide to surgical trials in epilepsy

Abstract: SummaryEpilepsy surgery is often the only effective treatment in appropriately selected patients with drug‐resistant epilepsy, a disease affecting about 30% of those with epilepsy. We review the evidence supporting the use of epilepsy surgery, with a focus on randomized controlled trials (RCTs). Second, we identify gaps in knowledge about the benefits of epilepsy surgery for certain populations, the challenges of individualizing the choice of surgery, and our lack of understanding of the mechanisms of surgical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 69 publications
0
8
0
Order By: Relevance
“…42 In a patient population with medically intractable focal epilepsy without a curative resective strategy, management options without pursuing further SEEG evaluation would include the following: (a) continued medical management with further AED trials (4%-7% chance of seizure freedom, 51% chance of >50% seizure reduction in this cohort), (b) VNS (0-1% chance of seizure freedom, 16%-21% chance of >50% seizure reduction), and (c) RNS (14%-15% chance of seizure freedom for at least 1 year, 29% chance of >50% seizure reduction). 43 The responder rate in our cohort (80%) was comparatively higher than any of these, suggesting that pursuing a B-SEEG implantation to craft a resective surgery may have greater potential to reduce seizures than continued medical management and traditional “palliative” procedures, even in suspected multifocal epilepsy.…”
Section: Discussionmentioning
confidence: 56%
“…42 In a patient population with medically intractable focal epilepsy without a curative resective strategy, management options without pursuing further SEEG evaluation would include the following: (a) continued medical management with further AED trials (4%-7% chance of seizure freedom, 51% chance of >50% seizure reduction in this cohort), (b) VNS (0-1% chance of seizure freedom, 16%-21% chance of >50% seizure reduction), and (c) RNS (14%-15% chance of seizure freedom for at least 1 year, 29% chance of >50% seizure reduction). 43 The responder rate in our cohort (80%) was comparatively higher than any of these, suggesting that pursuing a B-SEEG implantation to craft a resective surgery may have greater potential to reduce seizures than continued medical management and traditional “palliative” procedures, even in suspected multifocal epilepsy.…”
Section: Discussionmentioning
confidence: 56%
“…Prior reviews included either included only randomized controlled trials (RCTs) with limited follow‐up time, or retrospective chart reviews as well as prospective studies 12–16 . We conducted a systematic review and meta‐analysis of VNS, RNS, and DBS in the treatment of DRE to summarize the most up‐to‐date evidence on efficacy and tolerability for these modalities.…”
Section: Introductionmentioning
confidence: 99%
“…Even so, only one percent of the cases that could probably benefit from this procedure are referred for presurgical evaluation. With an average of 20 years or more from the onset of their disease, on the other hand, about half of the patients who undergo epilepsy surgery in the world continue with seizures [8,9] so it is of utmost importance to better predict the postoperative prognosis. The literature describes different clinical, surgical, electrophysiological, and imaging variables, which behave as prognostic factors.…”
Section: Introductionmentioning
confidence: 99%